Search

Search Constraints

You searched for: Author/Creator Valantin, Marc-Antoine

Search Results

1. Birth Country Influences the Choice of Antiretroviral Therapy in HIV-Infected Individuals: Experience From a French HIV Centre. (1st February 2023)

2. Characterization of viral rebounds on dual etravirine/raltegravir maintenance therapy (ANRS-163 ETRAL trial). (7th April 2020)

3. Compassionate Use of Hydroxychloroquine in Clinical Practice for Patients With Mild to Severe COVID-19 in a French University Hospital. (18th June 2020)

4. Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients – "En route for eradication"?. Issue 3 (September 2017)

5. Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study—authors' response. (20th September 2019)

6. Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study—authors' response. (20th September 2019)

7. Efficacy of intermittent short cycles of integrase inhibitor-based maintenance ART in virologically suppressed HIV patients. (16th January 2020)

8. Expanding the spectrum of HIV-associated myopathy. Issue 11 (11th April 2019)

9. Grazoprevir/elbasvir for the immediate treatment of recently acquired HCV genotype 1 or 4 infection in MSM. (19th April 2020)